This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Comments
Loading...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Lake Street analyst Frank Takkinen initiated coverage on Axogen, Inc. AXGN with a Buy rating and announced a price target of $30. Axogen shares closed at $17.25 on Friday. See how other analysts view this stock.
  • Craig-Hallum analyst John Wilkin initiated coverage on Personalis, Inc. PSNL with a Buy rating and announced a price target of $8. Personalis shares closed at $3.63 on Friday. See how other analysts view this stock.
  • William Blair analyst Andrew Brackmann initiated coverage on Butterfly Network, Inc. BFLY with an Outperform rating. Butterfly Network shares closed at $2.68 on Friday. See how other analysts view this stock.
  • Roth MKM analyst Craig Irwin initiated coverage on EZCORP, Inc. EZPW with a Buy rating and announced a price target of $16. EZCORP shares closed at $13.45 on Friday. See how other analysts view this stock.
  • Jefferies analyst Michael Yee initiated coverage on Blueprint Medicines Corporation BPMC with a Buy rating and announced a price target of $135. Blueprint Medicines shares closed at $89.58 on Friday. See how other analysts view this stock.

Considering buying BPMC stock? Here’s what analysts think:

AXGN Logo
AXGNAxogen Inc
$17.692.55%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum96.43
Growth81.70
Quality-
Value51.53
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In: